Cartilage Repair/Cartilage Regeneration Market worth $2.8 billion by 2028

Cartilage Repair / Cartilage Regeneration Market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $2.8 billion by 2028, growing at a CAGR of 17.2% from 2023 to 2028 according to a new report by MarketsandMarkets. Growth in the Cartilage Repair/Cartilage Regeneration market is mainly driven by the increasing prevalence of sports and accident-related orthopedic injuries and the increasing number of osteoarthritis cases expected to offer growth opportunities for players operating in the Cartilage Repair/Cartilage Regeneration market during the forecast period. However, the High cost of cartilage repair surgeries and Unfavorable reimbursement scenarios are restricting the growth of this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37493272&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Treatment modality segment is expected to account for the largest share in 2022.

By treatment modality the Cartilage Repair/Cartilage Regeneration market is divided into Cell-based and non-cell-based categories where cell-based segment includes chondrocyte transplantation, stem cells and growth factors. The non-cell-based which are the scaffolds and cell-free composites. Cell-based including chondrocyte transplantation, growth factors, and stem cells will drive the growth of the market due to the increasing number of osteoarthritis cases.

The hyaline cartilage segment held the largest market share in 2022.

By Application, the global Cartilage Repair/Cartilage Regeneration market is broadly segmented into hyaline cartilage and fibrocartilage. Hyaline cartilage is expected to grow highest in the upcoming years. The increasing number of hospitals and advancement in cartilage repair products will drive the growth of this application segment. Technological advancements, product developments and launches, and growing partnerships between key market players and hospitals are also supporting market growth.

The application site segment held the largest market share in the Cartilage Repair/Cartilage Regeneration market.

By application site, the global Cartilage Repair/Cartilage Regeneration market is broadly segmented into knee, hip, ankle & foot, and other application sites (nose and shoulder). The knee is expected to grow highest in the upcoming years. The increasing number of Knee replacement procedures performed worldwide is the major factor driving the growth of this application site segment. For Instance, according to the American Orthopedic Society for Sports Medicine, over 4 million knee arthroscopy procedures are performed worldwide each year; 700,000 are conducted in the US.

North America dominates the global Cartilage Repair/Cartilage Regeneration market.

Based on the region, the Cartilage Repair/Cartilage Regeneration market is segmented into North America, Europe, Asia Pacific and Rest of the world. The North American market is driven by the growing focus on growing government and private investments. For instance, In March 2020, the Government of Canada granted USD 6.9 million through the Stem Cell Network's competitive research funding, a body that supports Canada's most promising stem cell research. This funding is channelized to support nine translational projects and four clinical trials across Canada's regenerative medicine market, which comprises 200 researchers and trainees at 27 Canadian research institutes in Alberta, British Columbia, Quebec, and Ontario, as well as direct partnerships with several emerging biotechnology companies.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=37493272&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Cartilage Repair / Cartilage Regeneration Market Dynamics:

Drivers:

1. Increasing number of osteoarthritis cases

Restraints:

1. High cost of cartilage repair surgeries

Opportunities:

1. Technological advancements

Challenge:

1. Limitations of cartilage-based stem cell products

Key Market Players of Cartilage Repair / Cartilage Regeneration Industry:

The Key players in the Cartilage Repair/Cartilage Regeneration market are Smith+Nephew (UK), DePuy Synthes (Johnson & Johnson) (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Vericel Corporation (US), B. Braun Melsungen AG (US), Anika Therapeutics (US), CONMED Corporation (US), MEDIPOST (South Korea), RTI Surgical (US), Arthrex, Inc. (US), Regrow Biosciences (India), Geistlich Pharma AG (Switzerland), AlloSource (US), Orthocell Ltd, (Australia), Matricel GmbH (Germany), CartiHeal, Inc. (Israel), Regentis Biomaterials (Israel), Theracell Advanced Biotechnology (Greece), and LifeNet Health (US).

Breakdown of supply-side primary interviews by company type, designation, and region:

By Company Type: Tier 1 (30%), Tier 2 (44%), and Tier 3 (26%)
By Designation: C-level (30%), Director-level (33%), and Others (37%)
By Region: North America (40%), Europe (28%), Asia-Pacific (18%), RoW- (14%)

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=37493272&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
22.50 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cartilage-repair-regeneration-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/cartilage-repair-regeneration.asp

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

This release was published on openPR.